NOT-EB-24-018: Notice of NIBIB Participation in PAR-25-117: " Research With Activities Related to Diversity (ReWARD) (R01 Clinical Trial Optional)"

Notice of NIBIB Participation in PAR-25-117: " Research With Activities Related to Diversity (ReWARD) (R01 Clinical Trial Optional)"

Notice Number:

NOT-EB-24-018

Key Dates

Release Date:

November 13, 2024

Related Announcements

November 6, 2024 - Research With Activities Related to Diversity (ReWARD) (R01 Clinical Trial Optional). See NOFO PAR-25-117.

Issued by

National Institute of Biomedical Imaging and Bioengineering (NIBIB)

Purpose

The purpose of this Notice is to inform potential applicants that effective November 13, 2024, the National Institute of Biomedical Imaging and Bioengineering (NIBIB) will participate in PAR-25-117, "Research With Activities Related to Diversity (ReWARD) (R01 Clinical Trial Optional)", issued by the National Institutes of Health.

The following text has been added to reflect NIBIB’s participation in the NOFO:

Part 1. Overview Information

Components of Participating Organizations

National Institute of Biomedical Imaging and Bioengineering (NIBIB)

Catalog of Federal Domestic Assistance (CFDA) Number(s)

93.286

All other aspects of the NOFO remain the same.

Inquiries

Please direct all inquiries to:

Albert Avila, Ph.D.
National Institute of Biomedical Imaging and Bioengineering (NIBIB)
Telephone: 301-838-1720
Email: [email protected]